Ark Therapeutics

Ark Therapeutics Group plc is an innovative gene-based medicine company with operations in the UK and Finland. Ark seeks to capitalize on its pipeline of programs in high value areas of unmet medical need within vascular disease and cancer Ark has also developed a small molecule platform based on its acknowledged leadership in vascular biology and is currently working on an exciting NRP-1 antagonist program which is already the subject of interest from major pharmaceutical companies.
Type: NORMAL
Address: 4th Floor 44-46 Whitfield Street London W1T 2RJ
Website: http://www.arktherapeutics.com/main/index.php?content=home_page
Phone: +44 (0) 20 7388 7722
Fax: +44 (0) 20 7388 7805
Email: info@arktherapeutics.com
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.